These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 15728784

  • 1. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

  • 2. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
    Contreras G, Tozman E, Nahar N, Metz D.
    Lupus; 2005 Apr; 14 Suppl 1():s33-8. PubMed ID: 15803929
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [Abstract] [Full Text] [Related]

  • 5. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 6. Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis.
    Tse KC, Tang CS, Lam MF, Yap DY, Chan TM.
    J Rheumatol; 2009 Jan 04; 36(1):76-81. PubMed ID: 19004041
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Jan 04; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
    Chan TM, Tse KC, Tang CS, Lai KN, Li FK.
    Lupus; 2005 Jan 04; 14(4):265-72. PubMed ID: 15864912
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN.
    N Engl J Med; 2000 Oct 19; 343(16):1156-62. PubMed ID: 11036121
    [Abstract] [Full Text] [Related]

  • 10. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov 19; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 11. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Nov 19; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug 19; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 13. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
    Tse KC, Tang CS, Lio WI, Lam MF, Chan TM.
    Lupus; 2006 Aug 19; 15(6):371-9. PubMed ID: 16830884
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
    Feng L, Deng J, Huo DM, Wu QY, Liao YH.
    Nephrology (Carlton); 2013 Feb 19; 18(2):104-10. PubMed ID: 23113811
    [Abstract] [Full Text] [Related]

  • 15. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
    Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, MAINTAIN Nephritis Trial Group.
    Ann Rheum Dis; 2010 Dec 19; 69(12):2083-9. PubMed ID: 20833738
    [Abstract] [Full Text] [Related]

  • 16. Effects of mycophenolate mofetil for patients with crescentic lupus nephritis.
    Tang Z, Yang G, Yu C, Yu Y, Wang J, Hu W, Zeng C, Chen H, Liu Z, Li L.
    Nephrology (Carlton); 2008 Dec 19; 13(8):702-7. PubMed ID: 18771470
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
    J Rheumatol; 2015 Nov 19; 42(11):2082-91. PubMed ID: 26373566
    [Abstract] [Full Text] [Related]

  • 18. Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Tang CS, Chan TM.
    Rheumatology (Oxford); 2013 Mar 19; 52(3):480-6. PubMed ID: 23148090
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 19; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 20. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan 19; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.